News Announcement

Medicamen Biotech: Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter Ended 30 June 2026.

07-Aug-2026 Download PDF Medicamen Biotech

Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve the Unaudited Financial Results for the quarter ended 30 June 2026.